ATLASTaysha Gene Therapies (TSHA) earnings date: Nov 3, 2026
Taysha Gene Therapies (TSHA) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 3, 2026. Analysts expect EPS of -$0.13.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on TSHA
| Last price | $3.97 (-3.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.2% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Taysha Gene Therapies stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Taysha Gene Therapies reports on Nov 3, 2026. One email the day before, with ATLAS’s read on Taysha Gene Therapies. You can switch it off at any time.
Alert me before TSHA reportsFree to start. Creating an account takes under a minute.
Notify me when Taysha Gene Therapies reports
Track TSHA free Add Taysha Gene Therapies to a free ATLAS watchlist and see its next report date in one place.
TSHA earnings at a glance
| Next report (confirmed) | Tue, Nov 3, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.13 |
| Last report | Aug 11, 2026 · Miss |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | +8.4% |
| Average move around a report | ±3.0% (last 5) |
| Sector | Healthcare · Biotechnology |
Taysha Gene Therapies earnings history: last 5 reports
Taysha Gene Therapies last reported on Aug 11, 2026: EPS of -$0.13 against an estimate of -$0.11 (-18.2% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 11, 2026 | -$0.11 | -$0.13 | -18.2% | Miss | +0.6% |
| May 21, 2026 | $2.60 | $3.64 | +40.0% | Beat | 0.0% |
| May 6, 2026 | -$0.10 | -$0.11 | -10.0% | Miss | -3.9% |
| Mar 19, 2026 | -$0.10 | -$0.07 | +30.0% | Beat | -1.1% |
| Nov 4, 2025 | -$0.09 | -$0.09 | 0.0% | In line | -9.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for TSHA
See the fair value, the probability range and the earnings history of Taysha Gene Therapies on its ATLAS page.
Taysha Gene Therapies (TSHA) stock analysisPlans from €3.99 a month.
Taysha Gene Therapies earnings: frequently asked questions
When does Taysha Gene Therapies (TSHA) report earnings?
Taysha Gene Therapies is scheduled to report on Tuesday, November 3, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for TSHA?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.13 per share (USD). Estimates can change before the report.
How often does TSHA beat earnings estimates?
Of its last 5 reports with a recorded result, Taysha Gene Therapies beat the EPS estimate 2 times; the average surprise was +8.4%. Past results do not predict the next one.
How much does TSHA move around earnings?
Over its last 5 reports the stock moved an average of 3.0% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Taysha Gene Therapies beat earnings estimates last quarter?
Taysha Gene Therapies last reported on Aug 11, 2026: EPS of -$0.13 against an estimate of -$0.11 (-18.2% surprise), a miss.
How much does TSHA usually move in a day?
On a normal trading day the ATLAS model puts TSHA’s one-day range at about ±4.2%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 3, 2026
Educational information, not investment advice. Disclaimer